Abbott and Omada Health announced that they are partnering to integrate Abbott's FreeStyle Libre system, a continuous glucose monitoring (CGM) technology, with Omada Health's pioneering digital care program, aiming to create a new paradigm for people with Type 2 diabetes.
The integrated solution, powered by the companies' proprietary algorithms and analytics, aims to provide real-time glucose data and personalized care, which users can track on their smartphones through the Omada app, in the hopes that users will be able to better manage their diabetes. This digital system also has digital coaches that provide personalized recommendations for each participant.
"Partnering with Abbott to give individuals access to FreeStyle Libre as part of the Omada program will deliver a unique combination of personalized human coaching and technology-enabled care to support those goals." said Omada co-founder and chief executive officer Sean Duffy.
In an effort to eliminate fingersticking, the integration uses a smartphone scan that connects to the FreeStyle Libre sensor, which gives users glucose readings as well as trends overtime.
Omada Health will offer this integrated solution to employers and health plans. People diagnosed with Type 2 diabetes who are eligible will be guided through a tailored experience that includes an online physician consultation, obtaining a prescription of Freestyle Libre and delivery of a welcome kit that includes the CGM system and a wireless scale.
More information can be found at www.omadahealth.com.